- Home
- / CalciMedica
CalciMedica
Stock Price
$3.9
2024-10-29
Market Capitalization
$42.4 M
2024-10-29
CalciMedica Summary
Company Summary
- Overview
- CalciMedica (formerly known as Graybug Vision) is a biotechnology company that develops calcium release-activated calcium (CRAC) channel inhibitors. It focuses on developing therapies for inflammatory diseases of the pancreas, kidneys, lungs, and other organs.
- Type
- Public
- Status
- Active
- Founded
- 2007
- HQ
- La Jolla, CA, US | view all locations
- Website
- https://calcimedica.com/
- Cybersecurity rating
Table of Contents
Key People
Michael J. Dunn, President and Chief Operating Officer
Eric W. Roberts, Chief Business Officer and Vice Chairman
Sudarshan Hebbar, Chief Medical Officer
LocationsView all
1 location detected
La Jolla, CA HQ
United States
505 Coast S Blvd #307
CalciMedica Financials
Summary Financials
- Revenue (Q1, 2026)
- $106.0K
- Net income (Q1, 2026)
- $5.0M
- Cash (Q1, 2026)
- $8.2M
- EBIT (Q1, 2026)
- ($5.6M)